TNFSF11 and breast carcinoma: Similarly, in the presence of CO (BT-474/CO) a significant increase in the number of RANKL-nBMP-2-positive breast cancer cells was observed when compared to both the BT-474/CTRL (p = 0.022) and BT-474/HAP (p = 0.009) groups (Figure 5E).